Panagiotis Z Anastasiadis, PhD

  • 4266 Citations
  • 30 Scopus h-Index
1990 …2019
If you made any changes in Pure, your changes will be visible here soon.

Fingerprint Dive into the research topics where Panagiotis Z Anastasiadis is active. These topic labels come from the works of this person. Together they form a unique fingerprint.

  • 2 Similar Profiles
Cadherins Medicine & Life Sciences
rho GTP-Binding Proteins Medicine & Life Sciences
Neoplasms Medicine & Life Sciences
Catenins Medicine & Life Sciences
Adherens Junctions Medicine & Life Sciences
PC12 Cells Medicine & Life Sciences
Cell Movement Medicine & Life Sciences
Rho Guanine Nucleotide Exchange Factors Medicine & Life Sciences

Network Recent external collaboration on country level. Dive into details by clicking on the dots.

Projects 2004 2016

Rho Guanine Nucleotide Exchange Factors
Brain Neoplasms
Cell Movement
Cell Polarity
src-Family Kinases
Phosphatidylinositol 3-Kinases
Vascular Endothelial Growth Factor A

Mayo SPORE in Brain Cancer

Loftus, J. C., Anastasiadis, P. Z., Galanis, E., Buckner, J. C., Sarkaria, J. N., Giannini, C., Ballman, K. V., Yang, P., James, C. D., O'Neill, B. P. P., O'Neill, B. P., Uhm, J., O'Neill, B. P. & Uhm, J.

National Institutes of Health


Project: Research project

Brain Neoplasms
Measles virus
rho GTP-Binding Proteins
Cell Movement
Contact Inhibition

Research Output 1990 2019

  • 4266 Citations
  • 30 Scopus h-Index
  • 63 Article
  • 2 Chapter
  • 2 Review article
  • 1 Comment/debate

A phase 1 and randomized, placebo-controlled phase 2 trial of bevacizumab plus dasatinib in patients with recurrent glioblastoma: Alliance/North Central Cancer Treatment Group N0872

Galanis, E., Anderson, S. K., Twohy, E. L., Carrero, X. W., Dixon, J. G., Tran, D. D., Jeyapalan, S. A., Anderson, D. M., Kaufmann, T. J., Feathers, R. W., Giannini, C., Buckner, J. C., Anastasiadis, P. Z. & Schiff, D., Jan 1 2019, In : Cancer.

Research output: Contribution to journalArticle

National Cancer Institute (U.S.)

Close encounters of the RNAi kind: the silencing life of the adherens junctions

Kourtidis, A. & Anastasiadis, P. Z., Oct 1 2018, In : Current Opinion in Cell Biology. 54, p. 30-36 7 p.

Research output: Contribution to journalReview article

Adherens Junctions
RNA Interference
Disease Progression
2 Citations (Scopus)

Efficacy of the MDM2 inhibitor SAR405838 in glioblastoma is limited by poor distribution across the blood–brain barrier

Kim, M., Ma, D. J., Calligaris, D., Zhang, S., Feathers, R. W., Vaubel, R. A., Meaux, I., Mladek, A. C., Parrish, K. E., Jin, F., Barriere, C., Debussche, L., Watters, J., Tian, S., Decker, P. A., Eckel-Passow, J. E., Kitange, G. J., Johnson, A. J., Parney, I. F., Anastasiadis, P. Z. & 3 others, Agar, N. Y. R., Elmquist, W. F. & Sarkaria, J. N., Sep 1 2018, In : Molecular Cancer Therapeutics. 17, 9, p. 1893-1901 9 p.

Research output: Contribution to journalArticle

Pharmaceutical Preparations
Precision Medicine
8 Citations (Scopus)

Novel targeted therapy strategies for biliary tract cancers and hepatocellular carcinoma

Deleon, T. T., Ahn, D., Bogenberger, J. M., Anastasiadis, P. Z., Arora, M., Ramanathan, R. K., Aqel, B. A., Vasmatzis, G., Truty, M., Oklu, R., Bekaii-Saab, T. & Borad, M. J., Mar 1 2018, In : Future Oncology. 14, 6, p. 553-566 14 p.

Research output: Contribution to journalReview article

Biliary Tract Neoplasms
Hepatocellular Carcinoma
1 Citation (Scopus)

Simultaneous E-cadherin and PLEKHA7 expression negatively affects E-cadherin/EGFR mediated ovarian cancer cell growth

Rea, K., Roggiani, F., De Cecco, L., Raspagliesi, F., Carcangiu, M. L., Nair-Menon, J., Bagnoli, M., Bortolomai, I., Mezzanzanica, D., Canevari, S., Kourtidis, A., Anastasiadis, P. Z. & Tomassetti, A., Jul 11 2018, In : Journal of Experimental and Clinical Cancer Research. 37, 1, 146.

Research output: Contribution to journalArticle

Ovarian Neoplasms